Multimodality monitoring, inflammation, and neuroregeneration in subarachnoid hemorrhage

Neurosurgery

Volumn 75, Issue 6, 2014, Pages 678-689

  Nogueira, Adriano B ^a   Nogueira, Ariel B ^a   Veiga, José C Esteves ^b   Teixeira, Manoel J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Neural stem cells; Neurocritical care; Neurogenesis; Neuroinflammation; Neuroprotection

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; ENDOTHELIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GELATINASE A; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; FOLLOW UP; HUMAN; LABORATORY TEST; LUMBAR PUNCTURE; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROMONITORING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STUDY DESIGN; SUBARACHNOID HEMORRHAGE; VITAL SIGN;

EID: 84925935701     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000512     Document Type: Article

References (44)

1. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26(11):1341-1353.
2. Komotar RJ, Schmidt JM, Starke RM, et al. Resuscitation and critical care of poorgrade subarachnoid hemorrhage. Neurosurgery. 2009;64(3):397-410.
3. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci. 2007;10(11):1369-1376.
4. van Beek AH, Claassen JA, Rikkert MG, Jansen RW. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab. 2008;28(6):1071-1085.
5. Bellpart J, Fraser JF. Transcranial Doppler assessment of cerebral autoregulation. Ultrasound Med Biol. 2009;35(6):883-893.
6. Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol. 2006;26(7-8):1057-1083.
7. Vespa PM. Metabolic penumbra in intracerebral hemorrhage. Stroke. 2009;40(5): 1547-1548.
8. Pluta RM, Hansen-Schwartz J, Dreier J, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res. 2009;31 (2):151-158.
9. Dreier JP, Woitzik J, Fabricius M, et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain. 2006;129(pt 12):3224-3237.
10. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711-1737.
11. Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke. 2001;32(9):1989-1993.
12. Espiner EA, Leikis R, Ferch RD, et al. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol (Oxf). 2002;56(5):629-635.
13. Urra X, Cervera A, Villamor N, Planas AM, Chamorro A. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience. 2009;158 (3):1174-1183.
14. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J. 2009;276 (1):13-26.
15. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med. 2009;15(5):496-497.
16. Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15(2):192-199.
17. Ekdahl CT, Kokaia Z, Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience. 2009;158(3):1021-1029.
18. Kirschenbaum B, Nedergaard M, Preuss A, Barami K, Fraser RAR, Goldman SA. In vitro neuronal production and differentiation by precursor cells derived from the adult human forebrain. Cereb Cortex. 1994;4(6):576-589.
19. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med. 2002;8(9): 963-970.
20. Jin K, Wang X, Xie L, et al. Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci U S A. 2006;103(35):13198-13202.
21. Gould E. How widespread is adult neurogenesis in mammals? Nat Rev Neurosci. 2007;8(6):481-488.
22. Sgubin D, Aztiria E, Perin A, Longatti P, Leanza G. Activation of endogenous neural stem cells in the adult human brain following subarachnoid hemorrhage. J Neurosci Res. 2007;85(8):1647-1655.
23. Urbach A, Redecker C, Witte OW. Induction of neurogenesis in the adult dentate gyrus by cortical spreading depression. Stroke. 2008;39(11):3064-3072.
24. Yanamoto H, Miyamoto S, Tohnai N, et al. Induced spreading depression activates persistent neurogenesis in the subventricular zone, generating cells with markers for divided and early committed neurons in the caudate putamen and cortex. Stroke. 2005;36(7):1544-1550.
25. Xue JH, Yanamoto H, Nakajo Y, et al. Induced spreading depression evokes cell division of astrocytes in the subpial zone, generating neural precursor-like cells and new immature neurons in the adult cerebral cortex. Stroke. 2009;40(11): e606-613.
26. Nogueira AB, Sogayar MC, Colquhoun A, et al. Existence of a potential neurogenic system in the adult human brain. J Transl Med. 2014;12:75.
27. Schneider A, Krüger C, Steingleder T, et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005;115(8):2083-2098.
28. Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. J Neurosurg. 2009;111(1):171-180.
29. Kusaka G, IshikawaM, Nanda A, Granger DN, Zhang JH. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004; 24(8):916-925.
30. Saqqur M, Zygun D, Demchuk A. Role of transcranial Doppler in neurocritical care. Crit Care Med. 2007;35(suppl 5):S216-S223.
31. Claassen J, Mayer SA, Hirsch LJ. Continuous EEG monitoring in patients with subarachnoid hemorrhage. J Clin Neurophysiol. 2005;22(2):92-98.
32. Claassen J, Hirsch LJ, Kreiter KT, Du EY, Connolly ES, Emerson RG. Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol. 2004;115(12): 2699-2710.
33. Wartenberg KE, Schmidt JM, Mayer SA. Multimodality monitoring in neurocritical care. Crit Care Clin. 2007;23(3):507-538.
34. Fernandez A, Schmidt JM, Claassen J, et al. Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology. 2007;68(13):1013-1019.
35. Hillered L, Vespa PM, Hovda DA. Translational neurochemical research in acute human brain injury: the current status and potential future of cerebral microdialysis. J Neurotrauma. 2005;22(1):3-41.
36. Brain Trauma Foundation. Guidelines for the management of severe traumatic brain injury methods. J Neurotrauma. 2007;24(suppl 1):S3-S6.
37. Andrews PJ, Citerio G, Longhi L, et al. NICEM consensus on neurological monitoring in acute neurological disease. Intensive CareMed. 2008;34(8):1362-1370.
38. Stevens RD, Naval NS, Mirski MA, Citerio G, Andrews PJ. Intensive care of aneurysmal subarachnoid hemorrhage: an international survey. Intensive CareMed. 2009;35(9):1556-1566.
39. Linares G, Mayer SA. Hypothermia for the treatment of ischemic and hemorrhagic stroke. Crit Care Med. 2009;37(suppl 7):S243-S249.
40. Seder DB, van der Kloot TE. Methods of cooling: practical aspects of therapeutic temperature management. Crit Care Med. 2009;37(suppl 7):S211-S222.
41. De Georgia M, Deogaonkar A, Merrill TL. Methods to induce hypothermia. In: Mayer SA, Sessler DI, eds. Therapeutic Hypothermia. New York: Marcel Dekker; 2005:293-322.
42. Kreiter KT, Mayer SA, Howard G, et al. Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage. Stroke. 2009;40(7):2362-2367.
43. Ledford H. Drug markers questioned. Nature. 2008;452(7187):510-511.
44. Woltjer HH, Lansdorp B, Hilkens M, van der Hoeven JG. Predicting fluid responsiveness in the intensive care unit: a clinical guide. Neth J Crit Care. 2009; 13:31-37.